Literature DB >> 24827825

Measuring both procalcitonin and C-reactive protein for a diagnosis of sepsis in critically ill patients.

Hong-Xiang Li1, Zhong-Min Liu1, Shu-Jie Zhao1, Dong Zhang1, Shi-Ji Wang1, Yu-Shan Wang2.   

Abstract

BACKGROUND: The usefulness of procalcitonin (PCT) and C-reactive protein (CRP) as individual biomarkers, and in combination, for the identification of infections in a critically ill patient cohort was evaluated retrospectively.
METHODS: Best cut-off values for PCT and CRP for a diagnosis of sepsis in critically ill patients were determined using receiver operator characteristic (ROC) curve analysis. Both combined tests and individual tests were performed for PCT and CRP, with positive and negative results recorded, and accuracy evaluated using odds ratios (OR).
RESULTS: In the 55 critically ill patients studied, the best cut-off value for PCT for a diagnosis of sepsis was 1.1 ng/ml (sensitivity, specificity and negative predictive values [NPV] were 82%, 68% and 71%, respectively). In addition, the best cut-off value for CRP was 50.7 mg/l ( sensitivity, specificity and NPV of 90%, 68% and 83%, respectively). Measuring PCT and CRP in combination provided a sensitivity of 79%, a specificity of 86%, and a positive predictive value (PPV) of 90%. Diagnostic OR for the combination of biomarkers versus CRP alone (19 and 18, respectively) were greater than that for PCT (9).
CONCLUSION: For critically ill patients, CRP and CRP in combination with PCT were found to be suitable biomarkers for diagnosing sepsis, based on their NPV and PPV.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Biomarker; C-reactive protein; NPV; PPV; combination; procalcitonin; sensitivity; sepsis; specificity

Mesh:

Substances:

Year:  2014        PMID: 24827825     DOI: 10.1177/0300060514528483

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  6 in total

Review 1.  Procalcitonin: present and future.

Authors:  H H Liu; J B Guo; Y Geng; L Su
Journal:  Ir J Med Sci       Date:  2015-07-10       Impact factor: 1.568

Review 2.  Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?

Authors:  Dubravka Kojic; Benedikt H Siegler; Florian Uhle; Christoph Lichtenstern; Peter P Nawroth; Markus A Weigand; Stefan Hofer; Thorsten Brenner
Journal:  World J Exp Med       Date:  2015-05-20

3.  Presepsin as a diagnostic marker for sepsis: evidence from a bivariate meta-analysis.

Authors:  Xiaomeng Tong; Yongtong Cao; Min Yu; Chengwu Han
Journal:  Ther Clin Risk Manag       Date:  2015-07-02       Impact factor: 2.423

4.  Particularities of diagnosis in an elderly patient with neglected peritonitis: a case report.

Authors:  George Tocu; Dana Tutunaru; Raul Mihailov; Cristina Serban; Florentin Dimofte; Elena Niculet; Alin Laurentiu Tatu; Dorel Firescu
Journal:  J Int Med Res       Date:  2022-08       Impact factor: 1.573

5.  The Diagnostic Value of Plasma miRNA-497, cTnI, FABP3 and GPBB in Pediatric Sepsis Complicated with Myocardial Injury.

Authors:  Chengjiao Huang; Shuna Xiao; Zhi Xia; Ying Cheng; Yong Li; Wen Tang; Buyun Shi; Chenguang Qin; Hui Xu
Journal:  Ther Clin Risk Manag       Date:  2021-06-01       Impact factor: 2.423

6.  Cell-free DNA increase over first 48 hours in emergency intensive care unit predicts fatal outcome in patients with shock.

Authors:  Dun Ling Xia; Hong Zhang; Qing Li Luo; A Fang Zhang; Li Xin Zhu
Journal:  J Int Med Res       Date:  2016-09-27       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.